These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38057194)
41. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study. Vedeswari CP; Jayachandran S; Ganesan S Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705 [TBL] [Abstract][Full Text] [Related]
42. Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study. Arakeri G; Patil S; Maddur N; Rao Us V; Subash A; Patil S; Gao S; Brennan PA J Oral Pathol Med; 2020 Sep; 49(8):803-808. PubMed ID: 32652683 [TBL] [Abstract][Full Text] [Related]
44. Salivary and serum levels of lactate dehydrogenase in oral submucous fibrosis: A meta-analysis. Chen X; Chen T; Xie H; Guo J Medicine (Baltimore); 2024 Apr; 103(15):e37788. PubMed ID: 38608075 [TBL] [Abstract][Full Text] [Related]
45. Herbal derivatives in the management of mouth opening in oral submucous fibrosis-A network meta-analysis. Rajesh Kashyap R; Shanker Kashyap R Oral Dis; 2021 Oct; 27(7):1606-1615. PubMed ID: 32671872 [TBL] [Abstract][Full Text] [Related]
46. Curcumin for maintenance of remission in ulcerative colitis. Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948 [TBL] [Abstract][Full Text] [Related]
47. Interventions for the management of oral submucous fibrosis. Fedorowicz Z; Chan Shih-Yen E; Dorri M; Nasser M; Newton T; Shi L Cochrane Database Syst Rev; 2008 Oct; (4):CD007156. PubMed ID: 18843745 [TBL] [Abstract][Full Text] [Related]
48. Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. Shih YH; Wang TH; Shieh TM; Tseng YH Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208114 [TBL] [Abstract][Full Text] [Related]
49. Effectiveness of Aloe Vera and Antioxidant along with Physiotherapy in the Management of Oral Submucous Fibrosis. Singh N; Hebbale M; Mhapuskar A; Ul Nisa S; Thopte S; Singh S J Contemp Dent Pract; 2016 Jan; 17(1):78-84. PubMed ID: 27084867 [TBL] [Abstract][Full Text] [Related]
50. Comparison between Efficacy of Combined Use of Hyaluronidise and Triamcinolone versus Hyaluronidise, Triamcinolone Acetonide and Oral Colchicine in the Treatment of Oral Submucous Fibrosis. Mostafa MG; Khan JA; Ahmed S; Kamruzzaman M; Islam MR; Rahman MA; Alam MM; Khan L Mymensingh Med J; 2021 Jan; 30(1):79-84. PubMed ID: 33397855 [TBL] [Abstract][Full Text] [Related]
51. Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis. Lanjekar AB; Bhowate RR; Bakhle S; Narayane A; Pawar V; Gandagule R J Contemp Dent Pract; 2020 Jan; 21(1):83-90. PubMed ID: 32381807 [TBL] [Abstract][Full Text] [Related]
52. Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis. Kujan O; Mello FW; Warnakulasuriya S Oral Dis; 2021 Nov; 27(8):1936-1946. PubMed ID: 33205543 [TBL] [Abstract][Full Text] [Related]
53. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Lin HJ; Lin JC Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328 [TBL] [Abstract][Full Text] [Related]
54. Zinc and vitamin A can minimise the severity of oral submucous fibrosis. Dhariwal R; Mukherjee S; Mohanty SP; Chakraborty A; Ray JG; Chaudhuri K BMJ Case Rep; 2010 May; 2010():. PubMed ID: 22736755 [TBL] [Abstract][Full Text] [Related]
55. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis. Tilakaratne WM; Ekanayaka RP; Herath M; Jayasinghe RD; Sitheeque M; Amarasinghe H Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):224-31. PubMed ID: 27422421 [TBL] [Abstract][Full Text] [Related]
56. Prosthetic rehabilitation of oral submucous fibrosis patients: A systematic review of published case reports and case series. Patil S; Sarode SC; Sarode GS; Bhandi S; Awan KH; Ferrari M PLoS One; 2017; 12(9):e0184041. PubMed ID: 28877246 [TBL] [Abstract][Full Text] [Related]
57. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Qiu L; Gao C; Wang H; Ren Y; Li J; Li M; Du X; Li W; Zhang J Front Endocrinol (Lausanne); 2023; 14():1216708. PubMed ID: 37522129 [TBL] [Abstract][Full Text] [Related]
58. Pentoxifylline - A Novel Adjunct in the Management of Patients with Oral Submucous Fibrosis in Terai Population of Nepal: A Prospective Case Control Study. Wazir SS; Srivastava R Mymensingh Med J; 2022 Oct; 31(4):1170-1178. PubMed ID: 36189568 [TBL] [Abstract][Full Text] [Related]
59. A biomaterial-based therapy using a sodium hyaluronate/bioglass composite hydrogel for the treatment of oral submucous fibrosis. Guo ZX; Zhang Z; Yan JF; Xu HQ; Wang SY; Ye T; Han XX; Wang WR; Wang Y; Gao JL; Niu LN; Chang J; Jiao K Acta Biomater; 2023 Feb; 157():639-654. PubMed ID: 36509401 [TBL] [Abstract][Full Text] [Related]
60. Spirulina and pentoxyfilline - a novel approach for treatment of oral submucous fibrosis. Mulk BS; Deshpande P; Velpula N; Chappidi V; Chintamaneni RL; Goyal S J Clin Diagn Res; 2013 Dec; 7(12):3048-50. PubMed ID: 24551724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]